Nano Pharmasolutions Inc.
ESCONDIDO, CA · Founded 2019 · CIK 0001853364 · Biotech · Private
Nanoparticle drug formulation platform for improving bioavailability of poorly soluble pharmaceuticals
- Grants
- $256K
- 1 award
- Sector median: 1
- Raised
- $75K
- 1 Form D · Mar 2021
- 67 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 11
- 2 granted · 9 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202020212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $75,000 | |
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: A novel nanoformulation drug delivery platform to overcome poorly soluble drug challenges. | $255,961 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2658 | GALIBRA NEUROSCIENCE, INC. | — | $100K |
| 2659 | Blue Marlin Therapeutics, Inc. | — | $100K |
| 2660 | CINDER BIOLOGICAL, INC. | — | $100K |
| 2661 | Nano Pharmasolutions Inc. | — | $75K |
| 2662 | Normunity | — | — |
| 2663 | UNIVERSAL CELLS, INC. | — | $60K |
| 2664 | ISPIN, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- SEOK-KEUN KOHDirector
- SAEYEON LEEDirector · Executive Officer
- KAY OLMSTEAD, PH.D., MBADirector · Executive Officer
Patents
- Therapeutic Agent Nanoparticles And Methods Of Preparationgranted
- Therapeutic Agent Nanoparticles And Methods Of Preparationgranted
- Dry Powder Antiviral Compositions And Their Use For Treating Viral Infectionapplication
- Dry Powder Antiviral Compositions And Their Use For Treating Viral Infectionapplication
- Cannabidiol Nanoparticle Compositions And Therapeutic Applicationsapplication
- Therapeutic Agent Nanoparticles And Methods Of Preparationapplication
- Dry Powder Antiviral Compositions And Their Use For Treating Viral Infectionapplication
- Apomorphine Compositions And Therapeutic Applicationsapplication
- Therapeutic Agent Nanoparticles And Methods Of Preparationapplication
- Apomorphine Compositions And Therapeutic Applicationsapplication
- Cannabidiol Nanoparticle Compositionsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.